Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

27 resultsUpdated October 21, 2026

← Back to article

Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19

Critical Reviews™ in Therapeutic Drug Carrier Systems 42(6) (2025)

Eknath Kole; Krishna Jadhav; Raghuraj Singh; Rahul K. Verma; Aniruddha Chatterjee; Jitendra Naik

SARS-CoV-2: A Comprehensive Insight into DNA, RNA, Subunit, and Viral Vaccines

Medical Virology: From Pathogenesis to Disease Control (2025)

Shaheda Tabassum

VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions

Brazilian Archives of Biology and Technology 68 (2025)

Prakash Meghana; Mangalam Achuthananda Iyer Jayasri; Krishnamurthy Suthindhiran

Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial

Expert Review of Vaccines 24(1) (2025)

Bei-Fang Yang; Jing Jin; Xi-Ran He; Zhong-Hua Yang; Xiao’ai Qian; Ye-Qing Tong; Chang-Xian Ke; Zhao-Hong Li; Zhao-Xia Li; Lin-Feng Zhong; Ze-Hong Gan; Xian-Feng Zhang; Ying Zeng

Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery

Nucleic Acids Research 53(5) (2025)

Qi Yang; Bruce A Davidson; Petar Pajic; Xuyang Chen; Omer Gokcumen; Min Gao; Sriram Neelamegham

COVID-19: The vaccine development strategies

Understanding the Pandemic (2025)

Michael Zhipeng Yan; Ming Yang; Ching-Lung Lai

Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice

Vaccines 13(3) (2025)

Alessandra Gallinaro; Chiara Falce; Maria Franca Pirillo; Martina Borghi; Felicia Grasso; Andrea Canitano; Serena Cecchetti; Marco Baratella; Zuleika Michelini; Sabrina Mariotti; Maria Vincenza Chiantore; Iole Farina; Antonio Di Virgilio; Antonella Tinari; Gabriella Scarlatti; Donatella Negri; Andrea Cara

Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses

National Science Review 11(3) (2023)

Zichao Huang; Xinyu Zhuang; Liping Liu; Jiayu Zhao; Sheng Ma; Xinghui Si; Zhenyi Zhu; Fan Wu; Ningyi Jin; Mingyao Tian; Wantong Song; Xuesi Chen

A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity

eBioMedicine 110 (2024)

Yuhan Li; Xianwen Zhang; Wanbo Tai; Xinyu Zhuang; Huicheng Shi; Shumin Liao; Xinyang Yu; Rui Mei; Xingzhao Chen; Yanhong Huang; Yubin Liu; Jianying Liu; Yang Liu; Yibin Zhu; Penghua Wang; Mingyao Tian; Guocan Yu; Liang Li; Gong Cheng

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions

Vaccines 11(12) (2023)

Ryo Okuyama

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

Scientific Reports 14(1) (2024)

Monrat Chulanetra; Primana Punnakitikashem; Kodchakorn Mahasongkram; Wanpen Chaicumpa; Kantaphon Glab-ampai

A Critical Assessment of COVID-19 Genomic Vaccines

Current Topics in Medicinal Chemistry 23(27) (2023)

Dima A. Sabbah; Rima Hajjo; Suhair Sunoqrot

Platforms, advances, and technical challenges in virus-like particles-based vaccines

Frontiers in Immunology 14 (2023)

Reeshu Gupta; Kajal Arora; Sourav Singha Roy; Abyson Joseph; Ruchir Rastogi; Nupur Mehrotra Arora; Prabuddha K. Kundu

Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission

Pharmaceutics 16(2) (2024)

Gleb V. Petrov; Daria A. Galkina; Alena M. Koldina; Tatiana V. Grebennikova; Olesya V. Eliseeva; Yana Yu. Chernoryzh; Varvara V. Lebedeva; Anton V. Syroeshkin

An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines

Biomolecules 13(11) (2023)

Dona Susan Mathew; Tirtha Pandya; Het Pandya; Yuzen Vaghela; Selvakumar Subbian

An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines

Vaccines 11(9) (2023)

Doddy Irawan Setyo Utomo; Hamizah Suhaimi; Nor Azila Muhammad Azami; Fazren Azmi; Mohd Cairul Iqbal Mohd Amin; Jian Xu

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines

International Journal of Molecular Sciences 25(22) (2024)

Nelli S. Khudainazarova; Dmitriy L. Granovskiy; Olga A. Kondakova; Ekaterina M. Ryabchevskaya; Angelina O. Kovalenko; Ekaterina A. Evtushenko; Marina V. Arkhipenko; Nikolai A. Nikitin; Olga V. Karpova

Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate

Advanced Healthcare Materials 13(20) (2024)

Zibin Tan; Canchai Yang; Po‐han Lin; Sherif Ramadan; Weizhun Yang; Zahra Rashidi; Shuyao Lang; Fatemeh Shafieichaharberoud; Jia Gao; Xingling Pan; Nachy Soloff; Xuanjun Wu; Steven Bolin; Dohun Pyeon; Xuefei Huang

Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast

Vaccines 11(10) (2023)

Gaurav Nagar; Siddharth Jain; Meghraj Rajurkar; Rakesh Lothe; Harish Rao; Sourav Majumdar; Manish Gautam; Sergio A. Rodriguez-Aponte; Laura E. Crowell; J. Christopher Love; Prajakta Dandekar; Amita Puranik; Sunil Gairola; Umesh Shaligram; Ratnesh Jain